Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer
- Status
- COMPLETED
- Phase
- NA
Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Psychostimulants for Fatigue in Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A
Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE3
Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy
- Status
- COMPLETED
- Phase
- NA